Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details
Open AccessReview

An analysis of 13 patients with perforated gastric carcinoma: A surgeon's nightmare?

Cetin Kotan1 email, Aziz Sumer2 email, Murat Baser1 email, Remzi Kızıltan1 email and M Ali Carparlar1 email

1Department of Surgery, Faculty of Medicine, Yüzüncü Yil University, Van, Turkey

2Department of Surgery, Kaş State Hospital, Antalya, Turkey

author email corresponding author email

World Journal of Emergency Surgery 2008, 3:17doi:10.1186/1749-7922-3-17

Published: 10 May 2008

Abstract

Background and Objectives

Perforation is a rare complication of gastric carcinoma and generally not diagnosed preoperatively. To clarify the clinicopathologic characteristics of patients with this condition we reviewed 13 cases of gastric cancer perforation who required emergency surgery.

Methods

A total of 13 patients with gastric cancer perforation were retrospectively reviewed. The clinicopathological features including tumor stage and survival and also the type of treatment were analyzed and compared to literature data.

Results

There were 13 patients (10 males and 3 females) with a mean age of 59.0 ± 9.56 years. The incidence of perforated gastric cancer was 9.6% among gastric carcinoma and 4.2% of all gastric perforation cases. The perforation was more frequently in stage III–IV (2–10), but one case of stage II (T3N0M0) gastric cancer was also observed. None of the patients had curative resection or radical lymph-node dissection. Six (46%) patients were treated by palliative, local surgery. Emergency gastrectomy were performed in 7 (54%) patients. Overall 30-day mortality rate was % 46. The overall survival time was 128.2 ± 184.8 days for all patients, it was 52.8 ± 52.9 days for locally treated group, and 192.9 ± 235.4 days for patients who underwent resectional surgery. The difference between the treatment groups was not significant

Conclusion

Perforation usually occurs in advanced stages of gastric cancer. These patients had a poor prognosis because of the presence of advanced cancer.


© 1999-2008 BioMed Central Ltd unless otherwise stated < info@biomedcentral.com >   Terms and conditions